
Professor of Infectious Diseases The University of Texas MD Anderson Cancer Center Tweets and retweets are my own @MDAndersonNews
Houston - Texas
Joined October 2022
- Tweets52
- Following233
- Followers209
- Likes290
Ten-Year Trends in Attributable and Contributable Mortality of Culture-Positive Invasive Aspergillosis in Patients with Hematologic Malignancies: Have We Reached the “Ceiling Efficacy Effect” of Modern Antifungals? academic.oup.com/cid/article…
Ariel David Szvalb MD retweeted
10-Year Trends in Attributable and Contributable Mortality of Culture-Positive Invasive Aspergillosis in Patients with Hematologic Malignancies: Have We Reached the “Ceiling Efficacy Effect” of Modern Antifungals?
✅ Just Accepted
🔗 bit.ly/4yb2iAy
Ariel David Szvalb MD retweeted
Replying to @UTMDAnderson
10-Year Trends in Attributable and Contributable Mortality of Culture-Positive Invasive Aspergillosis in Patients with Hematologic Malignancies: Have We Reached the “Ceiling Efficacy Effect” of Modern Antifungals?
✅ Just Accepted
🔗 bit.ly/4yb2iAy
Ariel David Szvalb MD retweeted
【10-Year Trends in Attributable and Contributable Mortality of Culture-Positive Invasive Aspergillosis in Patients with Hematologic Malignancies】
We are pleased to share our recent article has been just accepted in @CIDJournal!
@ADSzvalb @adm_stewart @10e_John @MSG_ERC @UTMDAnderson
academic.oup.com/cid/advance…
Ariel David Szvalb MD retweeted
Getting Rosalind Franklin’s story right is crucial, because she has become a role model for women going into science
nature.com/articles/d41586-0…
Ariel David Szvalb MD retweeted
MD Anderson is proud to be named #1 in the nation for cancer care in @USNews’“Best Hospitals” ranking.
Read more: bit.ly/4lZOVwH
#BestHospitals #EndCancer
Ariel David Szvalb MD retweeted
👉👉👉Delighted to share our new paper 📑 led by Dr @KarenNahmod & Dr @kanagalshamanna ! 🙏 #pDC #BPDCN #CMMLsm | tandfonline.com/doi/full/10.… | #endcancer #leusm | @sanamloghavi @GMontalbanBravo @doctorpemm @SaWangMD #hemepath 🙌
Ariel David Szvalb MD retweeted
This is a needed correction.
If the system paid infectious disease doctors the same as dermatologists they would be equally popular fields
Rvu payments are garbage, prioritizing practices that don't work and are invasive over thinking. statnews.com/2024/11/20/rfk-…
Ariel David Szvalb MD retweeted
In the aftermath of the election results, I thought of this really interesting piece from 2022, written anonymously.
There's a lot here that's worth reading for us ID docs, whether we agree or not. #IDTwitter
@VPrasadMDMPH
drvinayprasad.com/p/why-no-o…
Percutaneous nephrostomy catheter-related infections in patients with gynaecological cancers: a multidisciplinary a… pubmed.ncbi.nlm.nih.gov/3769…
6
231
Ariel David Szvalb MD retweeted
【Percutaneous nephrostomy catheter-related infections】J Hosp Infect. 2023 Nov
👉Useful algorithm for management of one of the most frequent consults: PCN-related infections! @ADSzvalb @MDAndersonNews
#IDFellow #IDMedEd
doi.org/10.1016/j.jhin.2023.…
Ariel David Szvalb MD retweeted
Session 7 at #SH23 Workshop focuses on T-PLL and other T/NK neoplasms with leukemic involvement. #hemepath #lymsm #lymphoma @SaWangMD @KarenNahmod @ljmedeirosMD @monakashim1
Ariel David Szvalb MD retweeted
Israel is a long standing highly valued member of our council. Our thoughts are with the victims and their relatives.
Nothing in the world can justify this heinous and barbaric terror attack.
Ariel David Szvalb MD retweeted
And that’s our girl representing #hemepath @ our divisional party.
Taking this opportunity to thank @KarenNahmod & @Dowhankim our co-chief fellows who have spearheaded our #hemepathmda educational efforts in making the conferences accessible worldwide. Thank U Karen & Do 🤍🙏🏻
It’s the best time of the year!!! Let’s get this #graduation party started!!! 🍾🎓May the best two fellows win the grand prize 😉 @Rollsroycerah #PathTwitter
Accepting applications for 2025!!
Ariel David Szvalb MD retweeted
Major breakthrough in patient care!! A patch you wear for 24 hours that measures your blood pressure 100 times. Provides averages, daytime, nighttime blood pressures. Painless. No anxiety. One time disposable use. Now available at my clinic. From Israel. Scientifically validated
Acute Peritoneal Histoplasmosis Mimicking Ovarian Cancer and Review of the Literature on Histoplasma Peritonitis academic.oup.com/ofid/articl…
Ariel David Szvalb MD retweeted
Acute Peritoneal Histoplasmosis Mimicking Ovarian Cancer and Review of the Literature on Histoplasma Peritonitis
✅ Just Accepted
🔓 Open Access
🔗 https://nitter.cf/t.co/21FvEEn6xc
Ariel David Szvalb MD retweeted
【Publication announcement】OFID Jan 2023
Congratulations to @ADSzvalb, @eduardo_yepezg, Dr. Kontoyiannis and all other faculty! @MDAndersonNews
👉Acute Peritoneal Histoplasmosis Mimicking Ovarian Cancer
academic.oup.com/ofid/advanc…
Ariel David Szvalb MD retweeted
Chemo-free combination of ponatinib + blinatumomab is potentially curative in Ph+ ALL w/o need for intensive chemo or allo-SCT. This is new standard of care in Ph+ ALL.
Jabbour, Short, Kantarjian of @MDAndersonNews #Leukemia authors.elsevier.com/a/1g5k1… via @TheLancetHaem
#leusm
Ariel David Szvalb MD retweeted
New from @MDAndersonNews investigators | Prevention of device-related infections in patients with cancer: Current practice and future horizons acsjournals.onlinelibrary.wi…






























